Found: 13
Select item for more details and to access through your institution.
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
- Published in:
- 2020
- By:
- Publication type:
- journal article
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3461, doi. 10.1007/s00262-023-03497-1
- By:
- Publication type:
- Article
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2005, doi. 10.1007/s00262-023-03371-0
- By:
- Publication type:
- Article
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 4, p. 619, doi. 10.1007/s00262-019-02308-w
- By:
- Publication type:
- Article
Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma.
- Published in:
- JAMA Ophthalmology, 2015, v. 133, n. 8, p. 965, doi. 10.1001/jamaophthalmol.2015.1128
- By:
- Publication type:
- Article
BRAF mutation correlates with worse local-regional control following radiation therapy in patients with stage III melanoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of age‐related T‐cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: A prospective cohort study.
- Published in:
- Aging & Cancer, 2020, v. 1, n. 1-4, p. 58, doi. 10.1002/aac2.12012
- By:
- Publication type:
- Article
Impact of age-related T-cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: A prospective cohort study.
- Published in:
- Aging & Cancer, 2020, v. 1, n. 1, p. 58, doi. 10.1002/aac2.12012
- By:
- Publication type:
- Article
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. e625, doi. 10.1093/oncolo/oyad097
- By:
- Publication type:
- Article
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 5931, doi. 10.2147/OTT.S106288
- By:
- Publication type:
- Article
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 10, p. 1784, doi. 10.1002/cncr.35200
- By:
- Publication type:
- Article
Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2019, v. 257, n. 8, p. 1771, doi. 10.1007/s00417-019-04337-8
- By:
- Publication type:
- Article